Wade Hull
Hoofd Techniek/Wetenschap/O&O bij CRESCITA THERAPEUTICS INC.
Vermogen: 12 563 $ op 31-05-2024
Actieve functies van Wade Hull
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CRESCITA THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 01-03-2016 | - |
Loopbaan van Wade Hull
Eerdere bekende functies van Wade Hull
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS, INC. | Corporate Officer/Principal | 01-05-1996 | 01-12-1996 |
| NUVO PHARMACEUTICALS INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
ZARS Pharma, Inc.
 ZARS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZARS Pharma, Inc. develops and distributes drugs. It is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs, primarily for the treatment of pain, using its proprietary drug delivery technologies. The company was founded by Jie Zhang, Theodore H. Stanley, Larry D. Rigby and Michael A. Ashburn in 1996 and is headquartered in Salt Lake City, UT. | Hoofd Techniek/Wetenschap/O&O | 01-08-1998 | - |
Opleiding van Wade Hull
| University of Utah | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Canada | 3 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| UTAH MEDICAL PRODUCTS, INC. | Health Technology |
| CRESCITA THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
ZARS Pharma, Inc.
ZARS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZARS Pharma, Inc. develops and distributes drugs. It is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs, primarily for the treatment of pain, using its proprietary drug delivery technologies. The company was founded by Jie Zhang, Theodore H. Stanley, Larry D. Rigby and Michael A. Ashburn in 1996 and is headquartered in Salt Lake City, UT. | Health Technology |
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
